SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Progen Industries Ltd (PGLAF)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Henrik1/26/2007 2:50:44 AM
   of 349
 
PR from Progen ..................................................

Liver Cancer; Progen reports positive results for Phase II liver cancer trial
Drug Week, 2 February 2007, 324 words, (English)
2007 FEB 2 - (NewsRx.com) -- Progen Industries (PGL; PGLA) announced positive preliminary results demonstrating that PI-88 increased disease-free survival - time to tumor recurrence - by 76%.
(Document DRGW000020070126e3220008y)
More Like This

2. Liver Cancer; Progen reports positive results for Phase II liver cancer trial
Biotech Week, 31 January 2007, 324 words, (English)
2007 JAN 31 - (NewsRx.com) -- Progen Industries (PGL; PGLA) announced positive preliminary results demonstrating that PI-88 increased disease-free survival - time to tumor recurrence - by 76%.
(Document BIWK000020070126e31v0009k)
More Like This

3. Finance; Progen announces capital raising to progress PI-88 toward Phase III
Biotech Week, 31 January 2007, 374 words, (English)
2007 JAN 31 - (NewsRx.com) -- Progen Industries (PGL; PGLA) is raising A$20.0 million through an underwritten private share placement and will commence a share purchase plan to existing shareholders to partially fund the Phase III clinical ...
(Document BIWK000020070126e31v0007m)
More Like This

4. Liver Cancer; Progen reports positive results for Phase II liver cancer trial
Science Letter, 30 January 2007, 324 words, (English)
2007 JAN 30 - (NewsRx.com) -- Progen Industries (PGL; PGLA) announced positive preliminary results demonstrating that PI-88 increased disease-free survival - time to tumor recurrence - by 76%.
(Document SCLT000020070126e31u000ak)
More Like This

5. Finance; Progen announces capital raising to progress PI-88 toward Phase III
Science Letter, 30 January 2007, 374 words, (English)
2007 JAN 30 - (NewsRx.com) -- Progen Industries (PGL; PGLA) is raising A$20.0 million through an underwritten private share placement and will commence a share purchase plan to existing shareholders to partially fund the Phase III clinical ...
(Document SCLT000020070126e31u0007z)
More Like This

6. Liver Cancer; Progen reports positive results for Phase II liver cancer trial
Life Science Weekly, 30 January 2007, 326 words, (English)
2007 JAN 30 - (NewsRx.com) -- Progen Industries (PGL; PGLA) announced positive preliminary results demonstrating that PI-88 increased disease-free survival - time to tumor recurrence - by 76%.
(Document LFSW000020070126e31u000ak)
More Like This

7. Finance; Progen announces capital raising to progress PI-88 toward Phase III
Life Science Weekly, 30 January 2007, 376 words, (English)
2007 JAN 30 - (NewsRx.com) -- Progen Industries (PGL; PGLA) is raising A$20.0 million through an underwritten private share placement and will commence a share purchase plan to existing shareholders to partially fund the Phase III clinical ...
(Document LFSW000020070126e31u00080)
More Like This

8. Liver Cancer; Progen reports positive results for Phase II liver cancer trial
Cancer Weekly, 30 January 2007, 324 words, (English)
2007 JAN 30 - (NewsRx.com) -- Progen Industries (PGL; PGLA) announced positive preliminary results demonstrating that PI-88 increased disease-free survival - time to tumor recurrence - by 76%.
(Document NCIW000020070126e31u0002a)
More Like This

9. Liver Cancer; Progen reports positive results for Phase II liver cancer trial
Clinical Oncology Week, 29 January 2007, 326 words, (English)
2007 JAN 29 - (NewsRx.com) -- Progen Industries (PGL; PGLA) announced positive preliminary results demonstrating that PI-88 increased disease-free survival - time to tumor recurrence - by 76%.
(Document CONW000020070126e31t0001a)
More Like This

10. Finance; Progen announces capital raising to progress PI-88 toward Phase III
Clinical Oncology Week, 29 January 2007, 376 words, (English)
2007 JAN 29 - (NewsRx.com) -- Progen Industries (PGL; PGLA) is raising A$20.0 million through an underwritten private share placement and will commence a share purchase plan to existing shareholders to partially fund the Phase III clinical ...
(Document CONW000020070126e31t00014)
More Like This

11. Liver Cancer; Progen reports positive results for Phase II liver cancer trial
Health & Medicine Week, 29 January 2007, 328 words, (English)
2007 JAN 29 - (NewsRx.com) -- Progen Industries (PGL; PGLA) announced positive preliminary results demonstrating that PI-88 increased disease-free survival - time to tumor recurrence - by 76%.
(Document HAMW000020070126e31t000uh)
More Like This

12. Finance; Progen announces capital raising to progress PI-88 toward Phase III
Health & Medicine Week, 29 January 2007, 378 words, (English)
2007 JAN 29 - (NewsRx.com) -- Progen Industries (PGL; PGLA) is raising A$20.0 million through an underwritten private share placement and will commence a share purchase plan to existing shareholders to partially fund the Phase III clinical ...
(Document HAMW000020070126e31t000rx)
More Like This

13. Liver Cancer; Progen reports positive results for Phase II liver cancer trial
Clinical Trials Week, 29 January 2007, 326 words, (English)
2007 JAN 29 - (NewsRx.com) -- Progen Industries (PGL; PGLA) announced positive preliminary results demonstrating that PI-88 increased disease-free survival - time to tumor recurrence - by 76%.
(Document CTRW000020070126e31t00024)
More Like This

14. Liver Cancer; Progen reports positive results for Phase II liver cancer trial
Biotech Business Week, 29 January 2007, 326 words, (English)
2007 JAN 29 - (NewsRx.com) -- Progen Industries (PGL; PGLA) announced positive preliminary results demonstrating that PI-88 increased disease-free survival - time to tumor recurrence - by 76%.
(Document BTBW000020070126e31t0006m)
More Like This
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext